Cover The American Journal of Tropical Medicine and Hygiene
The American Journal of Tropical Medicine and Hygiene
Print ISSN:
0002-9637
  • 1

    Piscopo TV, Mallia Azzopardi C, 2007. Leishmaniasis. Postgrad Med J 83 :649–657.

  • 2

    Shrestha NK, 2006. Sodium stibogluconate. Clin Infect Dis 43 :1371–1372.

  • 3

    Lawn SD, Armstrong M, Chilton D, Whitty CJ, 2006. Electrocardiographic and biochemical adverse effects of sodium stibogluconate during treatment of cutaneous and mucosal leishmaniasis among returned travelers. Trans R Soc Trop Med Hyg 100 :264–269.

    • Search Google Scholar
    • Export Citation
  • 4

    Franke E, Wignall F, Cruz M, Rosales E, Tovar AA, Lucas CM, Llanos-Cuentas A, Berman JD, 1990. Efficacy and toxicity of sodium stibogluconate for mucosal leishmaniasis. Ann Intern Med 113 :934–940.

    • Search Google Scholar
    • Export Citation
  • 5

    Llanos-Cuentas A, Echevarria J, Cruz M, La Rosa A, Campos P, Campos M, Franke E, Berman J, Modabber E, Marr J, 1997. Efficacy of sodium stibogluconate alone and in combination with allopurinol for treatment of mucocutaneous leishmaniasis. Clin Infect Dis 25 :677–684.

    • Search Google Scholar
    • Export Citation
  • 6

    Davis A, 1968. Comparative trials of antimonial drugs in urinary schistosomiasis. Bull World Health Organ 38 :197–227.

  • 7

    Wortmann GW, Aronson NE, Byrd JC, Grever MR, Oster CN, 1998. Herpes zoster and lymphopenia associated with sodium stibogluconate therapy for cutaneous leishmaniasis. Clin Infect Dis 27 :509–512.

    • Search Google Scholar
    • Export Citation
  • 8

    Hartzell JD, Aronson NE, Nagaraja S, Whitman T, Hawkes CA, Wortmann G, 2006. Varicella zoster virus meningitis complicating sodium stibogluconate treatment for cutaneous leishmaniasis. Am J Trop Med Hyg 74 :591–592.

    • Search Google Scholar
    • Export Citation
  • 9

    Levin MJ, Smith JG, Kaufhold RM, Barber D, Hayward AR, Chan CY, Chan IS, Li DJ, Wang W, Keller PM, Shaw A, Silber JL, Schlienger K, Chalikonda I, Vessey SJ, Caulfield MJ, 2003. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine. J Infect Dis 188 :1336–1344.

    • Search Google Scholar
    • Export Citation
  • 10

    Gilden DH, Cohrs RJ, Mahalingam R, 2003. Clinical and molecular pathogenesis of varicella virus infection. Viral Immun 16 :243–258.

  • 11

    Klein NP, Holmes TH, Sharp MA, Heineman TC, Schleiss MR, Bernstein DI, Kemble G, Arvin AM, Dekker CL, 2006. Variability and gender differences in memory T cell immunity to varicella-zoster virus in healthy adults. Vaccine 14 :5913–5918.

    • Search Google Scholar
    • Export Citation
  • 12

    Levin MJ, Gershon AA, Weinberg A, Song LY, Fentin T, Nowak B, Pediatric AIDS Clinical Trials Group 265 Team, 2006. Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells. J Infect Dis 194 :247–255.

    • Search Google Scholar
    • Export Citation
Past two years Past Year Past 30 Days
Abstract Views 1 1 1
Full Text Views 282 89 1
PDF Downloads 35 25 1
 
 
 
 
 
 
 
 
 
 
 

Varicella Zoster Virus–Specific Immune Response after Treatment with Sodium Stibogluconate for Cutaneous Leishmaniasis

In-Kyu YoonAllergy and Immunology Division, Department of Clinical Investigation, and Infectious Disease Division, Walter Reed Army Medical Center, Washington, District of Columbia; Walter Reed Army Institute of Research, Rockville, Maryland

Search for other papers by In-Kyu Yoon in
Current site
Google Scholar
PubMedClose
,
Josephine CoxAllergy and Immunology Division, Department of Clinical Investigation, and Infectious Disease Division, Walter Reed Army Medical Center, Washington, District of Columbia; Walter Reed Army Institute of Research, Rockville, Maryland

Search for other papers by Josephine Cox in
Current site
Google Scholar
PubMedClose
,
Yaling ZhouAllergy and Immunology Division, Department of Clinical Investigation, and Infectious Disease Division, Walter Reed Army Medical Center, Washington, District of Columbia; Walter Reed Army Institute of Research, Rockville, Maryland

Search for other papers by Yaling Zhou in
Current site
Google Scholar
PubMedClose
,
Yvonne LukesAllergy and Immunology Division, Department of Clinical Investigation, and Infectious Disease Division, Walter Reed Army Medical Center, Washington, District of Columbia; Walter Reed Army Institute of Research, Rockville, Maryland

Search for other papers by Yvonne Lukes in
Current site
Google Scholar
PubMedClose
,
Brian ReinhardtAllergy and Immunology Division, Department of Clinical Investigation, and Infectious Disease Division, Walter Reed Army Medical Center, Washington, District of Columbia; Walter Reed Army Institute of Research, Rockville, Maryland

Search for other papers by Brian Reinhardt in
Current site
Google Scholar
PubMedClose
,
Anais Valencia-MicoltaAllergy and Immunology Division, Department of Clinical Investigation, and Infectious Disease Division, Walter Reed Army Medical Center, Washington, District of Columbia; Walter Reed Army Institute of Research, Rockville, Maryland

Search for other papers by Anais Valencia-Micolta in
Current site
Google Scholar
PubMedClose
, and
Glenn WortmannAllergy and Immunology Division, Department of Clinical Investigation, and Infectious Disease Division, Walter Reed Army Medical Center, Washington, District of Columbia; Walter Reed Army Institute of Research, Rockville, Maryland

Search for other papers by Glenn Wortmann in
Current site
Google Scholar
PubMedClose
View More View Less
DOI:
https://doi.org/10.4269/ajtmh.2008.78.402
Volume/Issue:
Volume 78: Issue 3
Page(s):
402–405
Restricted access
Get Permissions

Sodium stibogluconate has been associated with the reactivation of varicella zoster virus (VZV) in otherwise healthy adults who receive the drug as treatment for cutaneous leishmaniasis. Ten patients receiving daily sodium stibogluconate underwent phlebotomy at baseline and at day 10. Flow cytometry–based immunophenotyping, VZV-specific IgG levels, and lymphocyte proliferative responses and intracellular cytokine secretion to VZV, cytomegalovirus, tetanus toxoid, superantigen, and mitogens were performed at both time points. The absolute number of total leukocytes, total lymphocytes, and lymphocyte subsets decreased overall without predilection for any particular subset of lymphocytes, such that the percentage of the total lymphocyte population for each lymphocyte subset did not change significantly (except for a marginal increase in percentage of cytotoxic T cells). Antibodies to VZV were measured in seven patients before and after treatment, and did not change. Lymphocyte proliferative responses to VZV and other antigens and mitogens did not change from baseline. The mechanism for the increased rate of VZV reactivation after treatment with sodium stibogluconate remains undefined.

Copyright:
Copyright 2008 The American Society of Tropical Medicine 2008
Received:
10 Oct 2007
|
Accepted:
04 Jan 2008
|
Published Online:
Mar 2008
Save